International Classification of Retinopathy of Prematurity, Third Edition
The International Classification of Retinopathy of Prematurity is a consensus statement that creates a standard nomenclature for classification of retinopathy of prematurity (ROP). It was initially published in 1984, expanded in 1987, and revisited in 2005. This article presents a third revision, th...
Uložené v:
| Vydané v: | Ophthalmology (Rochester, Minn.) Ročník 128; číslo 10; s. e51 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
United States
01.10.2021
|
| Predmet: | |
| ISSN: | 1549-4713, 1549-4713 |
| On-line prístup: | Zistit podrobnosti o prístupe |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | The International Classification of Retinopathy of Prematurity is a consensus statement that creates a standard nomenclature for classification of retinopathy of prematurity (ROP). It was initially published in 1984, expanded in 1987, and revisited in 2005. This article presents a third revision, the International Classification of Retinopathy of Prematurity, Third Edition (ICROP3), which is now required because of challenges such as: (1) concerns about subjectivity in critical elements of disease classification; (2) innovations in ophthalmic imaging; (3) novel pharmacologic therapies (e.g., anti-vascular endothelial growth factor agents) with unique regression and reactivation features after treatment compared with ablative therapies; and (4) recognition that patterns of ROP in some regions of the world do not fit neatly into the current classification system.
Review of evidence-based literature, along with expert consensus opinion.
International ROP expert committee assembled in March 2019 representing 17 countries and comprising 14 pediatric ophthalmologists and 20 retinal specialists, as well as 12 women and 22 men.
The committee was initially divided into 3 subcommittees-acute phase, regression or reactivation, and imaging-each of which used iterative videoconferences and an online message board to identify key challenges and approaches. Subsequently, the entire committee used iterative videoconferences, 2 in-person multiday meetings, and an online message board to develop consensus on classification.
Consensus statement.
The ICROP3 retains current definitions such as zone (location of disease), stage (appearance of disease at the avascular-vascular junction), and circumferential extent of disease. Major updates in the ICROP3 include refined classification metrics (e.g., posterior zone II, notch, subcategorization of stage 5, and recognition that a continuous spectrum of vascular abnormality exists from normal to plus disease). Updates also include the definition of aggressive ROP to replace aggressive-posterior ROP because of increasing recognition that aggressive disease may occur in larger preterm infants and beyond the posterior retina, particularly in regions of the world with limited resources. ROP regression and reactivation are described in detail, with additional description of long-term sequelae.
These principles may improve the quality and standardization of ROP care worldwide and may provide a foundation to improve research and clinical care. |
|---|---|
| AbstractList | The International Classification of Retinopathy of Prematurity is a consensus statement that creates a standard nomenclature for classification of retinopathy of prematurity (ROP). It was initially published in 1984, expanded in 1987, and revisited in 2005. This article presents a third revision, the International Classification of Retinopathy of Prematurity, Third Edition (ICROP3), which is now required because of challenges such as: (1) concerns about subjectivity in critical elements of disease classification; (2) innovations in ophthalmic imaging; (3) novel pharmacologic therapies (e.g., anti-vascular endothelial growth factor agents) with unique regression and reactivation features after treatment compared with ablative therapies; and (4) recognition that patterns of ROP in some regions of the world do not fit neatly into the current classification system.
Review of evidence-based literature, along with expert consensus opinion.
International ROP expert committee assembled in March 2019 representing 17 countries and comprising 14 pediatric ophthalmologists and 20 retinal specialists, as well as 12 women and 22 men.
The committee was initially divided into 3 subcommittees-acute phase, regression or reactivation, and imaging-each of which used iterative videoconferences and an online message board to identify key challenges and approaches. Subsequently, the entire committee used iterative videoconferences, 2 in-person multiday meetings, and an online message board to develop consensus on classification.
Consensus statement.
The ICROP3 retains current definitions such as zone (location of disease), stage (appearance of disease at the avascular-vascular junction), and circumferential extent of disease. Major updates in the ICROP3 include refined classification metrics (e.g., posterior zone II, notch, subcategorization of stage 5, and recognition that a continuous spectrum of vascular abnormality exists from normal to plus disease). Updates also include the definition of aggressive ROP to replace aggressive-posterior ROP because of increasing recognition that aggressive disease may occur in larger preterm infants and beyond the posterior retina, particularly in regions of the world with limited resources. ROP regression and reactivation are described in detail, with additional description of long-term sequelae.
These principles may improve the quality and standardization of ROP care worldwide and may provide a foundation to improve research and clinical care. The International Classification of Retinopathy of Prematurity is a consensus statement that creates a standard nomenclature for classification of retinopathy of prematurity (ROP). It was initially published in 1984, expanded in 1987, and revisited in 2005. This article presents a third revision, the International Classification of Retinopathy of Prematurity, Third Edition (ICROP3), which is now required because of challenges such as: (1) concerns about subjectivity in critical elements of disease classification; (2) innovations in ophthalmic imaging; (3) novel pharmacologic therapies (e.g., anti-vascular endothelial growth factor agents) with unique regression and reactivation features after treatment compared with ablative therapies; and (4) recognition that patterns of ROP in some regions of the world do not fit neatly into the current classification system.PURPOSEThe International Classification of Retinopathy of Prematurity is a consensus statement that creates a standard nomenclature for classification of retinopathy of prematurity (ROP). It was initially published in 1984, expanded in 1987, and revisited in 2005. This article presents a third revision, the International Classification of Retinopathy of Prematurity, Third Edition (ICROP3), which is now required because of challenges such as: (1) concerns about subjectivity in critical elements of disease classification; (2) innovations in ophthalmic imaging; (3) novel pharmacologic therapies (e.g., anti-vascular endothelial growth factor agents) with unique regression and reactivation features after treatment compared with ablative therapies; and (4) recognition that patterns of ROP in some regions of the world do not fit neatly into the current classification system.Review of evidence-based literature, along with expert consensus opinion.DESIGNReview of evidence-based literature, along with expert consensus opinion.International ROP expert committee assembled in March 2019 representing 17 countries and comprising 14 pediatric ophthalmologists and 20 retinal specialists, as well as 12 women and 22 men.PARTICIPANTSInternational ROP expert committee assembled in March 2019 representing 17 countries and comprising 14 pediatric ophthalmologists and 20 retinal specialists, as well as 12 women and 22 men.The committee was initially divided into 3 subcommittees-acute phase, regression or reactivation, and imaging-each of which used iterative videoconferences and an online message board to identify key challenges and approaches. Subsequently, the entire committee used iterative videoconferences, 2 in-person multiday meetings, and an online message board to develop consensus on classification.METHODSThe committee was initially divided into 3 subcommittees-acute phase, regression or reactivation, and imaging-each of which used iterative videoconferences and an online message board to identify key challenges and approaches. Subsequently, the entire committee used iterative videoconferences, 2 in-person multiday meetings, and an online message board to develop consensus on classification.Consensus statement.MAIN OUTCOME MEASURESConsensus statement.The ICROP3 retains current definitions such as zone (location of disease), stage (appearance of disease at the avascular-vascular junction), and circumferential extent of disease. Major updates in the ICROP3 include refined classification metrics (e.g., posterior zone II, notch, subcategorization of stage 5, and recognition that a continuous spectrum of vascular abnormality exists from normal to plus disease). Updates also include the definition of aggressive ROP to replace aggressive-posterior ROP because of increasing recognition that aggressive disease may occur in larger preterm infants and beyond the posterior retina, particularly in regions of the world with limited resources. ROP regression and reactivation are described in detail, with additional description of long-term sequelae.RESULTSThe ICROP3 retains current definitions such as zone (location of disease), stage (appearance of disease at the avascular-vascular junction), and circumferential extent of disease. Major updates in the ICROP3 include refined classification metrics (e.g., posterior zone II, notch, subcategorization of stage 5, and recognition that a continuous spectrum of vascular abnormality exists from normal to plus disease). Updates also include the definition of aggressive ROP to replace aggressive-posterior ROP because of increasing recognition that aggressive disease may occur in larger preterm infants and beyond the posterior retina, particularly in regions of the world with limited resources. ROP regression and reactivation are described in detail, with additional description of long-term sequelae.These principles may improve the quality and standardization of ROP care worldwide and may provide a foundation to improve research and clinical care.CONCLUSIONSThese principles may improve the quality and standardization of ROP care worldwide and may provide a foundation to improve research and clinical care. |
| Author | Shapiro, Michael Fleck, Brian W Lepore, Domenico Blair, Michael Vinekar, Anand Ells, Anna Kusaka, Shunji Özdek, Şengül Dai, Shuan Fielder, Alistair R Chiang, Michael F Berrocal, Audina Lorenz, Birgit Wallace, David K Good, William V Ademola-Popoola, Dupe Chen, Yi Holmstrom, Gerd Stahl, Andreas Capone, Jr, Antonio Elizabeth Hartnett, M Toth, Cynthia Wu, Wei-Chi Quinn, Graham E Kychenthal, Andrés Binenbaum, Gil Peter Campbell, J Ostmo, Susan R Visser, Linda Paul Chan, R V Martinez-Castellanos, Maria Ana Reynolds, James D Zhao, Peiquan Shah, Parag K Zin, Andrea |
| Author_xml | – sequence: 1 givenname: Michael F surname: Chiang fullname: Chiang, Michael F email: michael.chiang@nih.gov organization: National Eye Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: michael.chiang@nih.gov – sequence: 2 givenname: Graham E surname: Quinn fullname: Quinn, Graham E organization: Division of Ophthalmology, Children's Hospital of Philadelphia, Scheie Eye Institute, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania – sequence: 3 givenname: Alistair R surname: Fielder fullname: Fielder, Alistair R organization: Department of Optometry and Visual Science, University of London, London, United Kingdom – sequence: 4 givenname: Susan R surname: Ostmo fullname: Ostmo, Susan R organization: Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon – sequence: 5 givenname: R V surname: Paul Chan fullname: Paul Chan, R V organization: Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois – sequence: 6 givenname: Audina surname: Berrocal fullname: Berrocal, Audina organization: Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida – sequence: 7 givenname: Gil surname: Binenbaum fullname: Binenbaum, Gil organization: Division of Ophthalmology, Children's Hospital of Philadelphia, Scheie Eye Institute, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania – sequence: 8 givenname: Michael surname: Blair fullname: Blair, Michael organization: Retina Consultants, Ltd., Des Plaines, Illinois; Department of Ophthalmology, University of Chicago, Chicago, Illinois – sequence: 9 givenname: J surname: Peter Campbell fullname: Peter Campbell, J organization: Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Oregon – sequence: 10 givenname: Antonio surname: Capone, Jr fullname: Capone, Jr, Antonio organization: Associated Retinal Consultants, PC, Royal Oak, Michigan, and Department of Ophthalmology, Oakland University, William Beaumont Hospital School of Medicine, Auburn Hills, Michigan – sequence: 11 givenname: Yi surname: Chen fullname: Chen, Yi organization: Department of Ophthalmology, China-Japan Friendship Hospital, Beijing, China – sequence: 12 givenname: Shuan surname: Dai fullname: Dai, Shuan organization: Ophthalmology Department, Queensland Children's Hospital, Brisbane, Australia – sequence: 13 givenname: Anna surname: Ells fullname: Ells, Anna organization: Calgary Retina Consultants, Calgary, Canada – sequence: 14 givenname: Brian W surname: Fleck fullname: Fleck, Brian W organization: Department of Ophthalmology, University of Edinburgh, Edinburgh, United Kingdom – sequence: 15 givenname: William V surname: Good fullname: Good, William V organization: Smith-Kettlewell Eye Research Institute, San Francisco, California – sequence: 16 givenname: M surname: Elizabeth Hartnett fullname: Elizabeth Hartnett, M organization: Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah, Salt Lake City, Utah – sequence: 17 givenname: Gerd surname: Holmstrom fullname: Holmstrom, Gerd organization: Department Neuroscience/Ophthalmology, Uppsala University, Uppsala, Sweden – sequence: 18 givenname: Shunji surname: Kusaka fullname: Kusaka, Shunji organization: Department of Ophthalmology, Kindai University, Osakasayama, Japan – sequence: 19 givenname: Andrés surname: Kychenthal fullname: Kychenthal, Andrés organization: Department of Ophthalmology, KYDOFT Foundation, Santiago, Chile – sequence: 20 givenname: Domenico surname: Lepore fullname: Lepore, Domenico organization: A. Gemelli Foundation IRCSS, Department of Ageing and Neuroscience, Catholic University of the Sacred Heart, Rome, Italy – sequence: 21 givenname: Birgit surname: Lorenz fullname: Lorenz, Birgit organization: Department of Ophthalmology, Justus-Liebig-University Giessen, Giessen, Germany; Department of Ophthalmology, Universitaetsklinikum Bonn, Bonn, Germany – sequence: 22 givenname: Maria Ana surname: Martinez-Castellanos fullname: Martinez-Castellanos, Maria Ana organization: Retina Department, Asociación para Evitar la Ceguera en México, Mexico City, Mexico – sequence: 23 givenname: Şengül surname: Özdek fullname: Özdek, Şengül organization: Department of Ophthalmology, School of Medicine, Gazi University, Ankara, Turkey – sequence: 24 givenname: Dupe surname: Ademola-Popoola fullname: Ademola-Popoola, Dupe organization: Department of Ophthalmology, University of Ilorin, Ilorin, Nigeria – sequence: 25 givenname: James D surname: Reynolds fullname: Reynolds, James D organization: Ross Eye Institute, Department of Ophthalmology, University at Buffalo, Buffalo, New York – sequence: 26 givenname: Parag K surname: Shah fullname: Shah, Parag K organization: Department of Pediatric Retina and Ocular Oncology, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India – sequence: 27 givenname: Michael surname: Shapiro fullname: Shapiro, Michael organization: Retina Consultants, Ltd., Des Plaines, Illinois – sequence: 28 givenname: Andreas surname: Stahl fullname: Stahl, Andreas organization: Department of Ophthalmology, University Medicine Greifswald, Greifswald, Germany – sequence: 29 givenname: Cynthia surname: Toth fullname: Toth, Cynthia organization: Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina – sequence: 30 givenname: Anand surname: Vinekar fullname: Vinekar, Anand organization: Department of Pediatric Retina, Narayana Nethralaya Eye Institute, Bangalore, Karnataka, India – sequence: 31 givenname: Linda surname: Visser fullname: Visser, Linda organization: Department of Ophthalmology, University of KwaZulu-Natal, Durban, South Africa – sequence: 32 givenname: David K surname: Wallace fullname: Wallace, David K organization: Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana – sequence: 33 givenname: Wei-Chi surname: Wu fullname: Wu, Wei-Chi organization: Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taoyuan, Taiwan, and Chang Gung University, College of Medicine, Taoyuan, Taiwan – sequence: 34 givenname: Peiquan surname: Zhao fullname: Zhao, Peiquan organization: Department of Ophthalmology, Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China – sequence: 35 givenname: Andrea surname: Zin fullname: Zin, Andrea organization: Clinical Research Unit, Fernandes Figueira Institute, FIOCRUZ, Rio de Janeiro, Brazil |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34247850$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj8tKxDAYhYMozkXfQKRLF7bm8idtlzKMOjCgyLguSZvQDG1Sm3Qxb6-jI7g6Fz4OnAU6d95phG4Izggm4mGf-aGNrcwopiTDPMOMnKE54VCmkBN2_s_P0CKEPcZYCAaXaMaAQl5wPEebjYt6dDJa72SXrDoZgjW2_ikSb5J3Ha3zg4zt4RjfRt3LOI02Hu6TXWvHJlk39ghfoQsju6CvT7pEH0_r3eol3b4-b1aP27TmAmLKALRi0BigumaqFFTWEigHahQUhulcUMMUL4qCGCEMzkuioWygzGussKJLdPe7O4z-c9IhVr0Nte466bSfQkU5x4JRQctv9PaETqrXTTWMtpfjofq7T78AOCJgGQ |
| CitedBy_id | crossref_primary_10_1111_aos_16625 crossref_primary_10_1007_s00383_022_05095_1 crossref_primary_10_1186_s12886_024_03434_5 crossref_primary_10_1038_s41433_023_02824_1 crossref_primary_10_1038_s41598_024_66483_2 crossref_primary_10_3389_fped_2025_1576979 crossref_primary_10_1007_s00417_025_06743_7 crossref_primary_10_36660_abc_20240635 crossref_primary_10_1016_j_jaapos_2021_09_004 crossref_primary_10_1111_jpc_16504 crossref_primary_10_3389_fnut_2025_1582519 crossref_primary_10_1016_j_survophthal_2023_06_010 crossref_primary_10_1080_17469899_2023_2200934 crossref_primary_10_3389_fped_2023_1099614 crossref_primary_10_1111_aos_16622 crossref_primary_10_1515_cclm_2023_1282 crossref_primary_10_1111_jpc_16621 crossref_primary_10_1055_a_2698_0900 crossref_primary_10_1038_s41372_024_01962_y crossref_primary_10_1097_IAE_0000000000003590 crossref_primary_10_1016_j_jpeds_2024_114270 crossref_primary_10_1136_bmjophth_2022_001216 crossref_primary_10_1016_j_resplu_2025_100905 crossref_primary_10_1136_bmjopen_2025_101442 crossref_primary_10_4103_sjopt_sjopt_276_21 crossref_primary_10_3390_children12060755 crossref_primary_10_1186_s13052_025_02033_4 crossref_primary_10_1016_j_mvr_2024_104689 crossref_primary_10_1001_jamanetworkopen_2022_51512 crossref_primary_10_1055_a_2679_1788 crossref_primary_10_1111_ped_15668 crossref_primary_10_1016_j_jaapos_2025_104113 crossref_primary_10_1002_med_22092 crossref_primary_10_1038_s41598_025_92205_3 crossref_primary_10_1007_s10456_024_09948_2 crossref_primary_10_1007_s00431_023_05063_4 crossref_primary_10_1007_s00247_024_05869_w crossref_primary_10_4103_ijo_IJO_2254_22 crossref_primary_10_1007_s10489_023_04766_3 crossref_primary_10_1007_s00417_025_06820_x crossref_primary_10_1097_IAE_0000000000004206 crossref_primary_10_1002_uog_26070 crossref_primary_10_1007_s10792_025_03720_1 crossref_primary_10_1167_iovs_65_12_35 crossref_primary_10_1111_aos_15753 crossref_primary_10_1111_aos_15751 crossref_primary_10_14734_PN_2025_36_2_43 crossref_primary_10_3390_children11040475 crossref_primary_10_3390_jcm11185361 crossref_primary_10_7759_cureus_36176 crossref_primary_10_7759_cureus_73286 crossref_primary_10_1016_j_xops_2024_100663 crossref_primary_10_1038_s41390_023_02559_5 crossref_primary_10_1007_s10384_022_00921_4 crossref_primary_10_1016_j_jri_2025_104636 crossref_primary_10_1038_s41433_024_03184_0 crossref_primary_10_1007_s00431_023_05229_0 crossref_primary_10_1016_j_ajo_2023_12_008 crossref_primary_10_4103_IJO_IJO_2024_23 crossref_primary_10_1371_journal_pone_0307903 crossref_primary_10_1007_s13246_025_01565_7 crossref_primary_10_1001_jama_2022_9163 crossref_primary_10_3390_children12020127 crossref_primary_10_3390_antiox13020148 crossref_primary_10_1136_archdischild_2025_328635 crossref_primary_10_3390_nu16172904 crossref_primary_10_1016_j_jaapos_2024_104053 crossref_primary_10_1097_IAE_0000000000003541 crossref_primary_10_1371_journal_pone_0319739 crossref_primary_10_3390_ijms23158529 crossref_primary_10_1007_s12098_024_05394_6 crossref_primary_10_3390_bioengineering11080792 crossref_primary_10_3390_medicina61010149 crossref_primary_10_1007_s10384_025_01199_y crossref_primary_10_1159_000538907 crossref_primary_10_1186_s13052_024_01776_w crossref_primary_10_1186_s12886_025_03869_4 crossref_primary_10_3928_19382359_20230613_06 crossref_primary_10_3389_fmed_2022_911095 crossref_primary_10_3390_jcm11010039 crossref_primary_10_1007_s11302_024_09986_x crossref_primary_10_4103_sjopt_sjopt_220_21 crossref_primary_10_3928_01913913_20221010_01 crossref_primary_10_1080_20469047_2022_2054916 crossref_primary_10_1016_j_dib_2023_109839 crossref_primary_10_1111_papr_13138 crossref_primary_10_3390_diagnostics15050571 crossref_primary_10_4103_IJO_IJO_754_23 crossref_primary_10_7759_cureus_84589 crossref_primary_10_1016_j_oret_2024_01_013 crossref_primary_10_1016_j_ophtha_2023_09_032 crossref_primary_10_1136_archdischild_2024_327003 crossref_primary_10_1080_08164622_2022_2053329 crossref_primary_10_1055_a_2051_8544 crossref_primary_10_1096_fba_2024_00059 crossref_primary_10_1136_bjo_2024_326932 crossref_primary_10_4274_tjo_galenos_2024_93464 crossref_primary_10_1007_s10792_022_02615_9 crossref_primary_10_4103_IJO_IJO_2999_22 crossref_primary_10_1136_bcr_2024_261444 crossref_primary_10_1016_j_xops_2025_100903 crossref_primary_10_1016_j_oret_2024_01_008 crossref_primary_10_1177_11206721221136314 crossref_primary_10_1007_s00431_024_05595_3 crossref_primary_10_4103_sjopt_sjopt_219_21 crossref_primary_10_1080_09286586_2022_2084757 crossref_primary_10_1097_ICU_0000000000001030 crossref_primary_10_1016_j_ymthe_2024_03_025 crossref_primary_10_1097_MD_0000000000043578 crossref_primary_10_1016_j_jaapos_2024_104038 crossref_primary_10_1186_s13052_023_01414_x crossref_primary_10_1016_j_ijnurstu_2024_104784 crossref_primary_10_1055_a_2236_4003 crossref_primary_10_1542_peds_2024_065963 crossref_primary_10_1016_j_xops_2025_100912 crossref_primary_10_1049_ell2_13267 crossref_primary_10_1016_j_survophthal_2023_05_004 crossref_primary_10_1371_journal_pone_0323470 crossref_primary_10_1159_000529393 crossref_primary_10_3390_diagnostics13122105 crossref_primary_10_3928_01913913_20250619_03 crossref_primary_10_1016_j_jcjo_2025_04_016 crossref_primary_10_3389_fped_2024_1414185 crossref_primary_10_1001_jamaophthalmol_2023_1310 crossref_primary_10_1016_j_oret_2023_09_023 crossref_primary_10_1002_jpen_2483 crossref_primary_10_1080_14767058_2025_2497058 crossref_primary_10_1136_bmjophth_2024_002036 crossref_primary_10_1542_neo_26_6_025 crossref_primary_10_4103_IJO_IJO_161_24 crossref_primary_10_1542_neo_26_6_023 crossref_primary_10_1186_s12886_023_03156_0 crossref_primary_10_1186_s12886_025_03867_6 crossref_primary_10_3389_fmed_2024_1421894 crossref_primary_10_4103_meajo_meajo_56_22 crossref_primary_10_1177_19345798251359897 crossref_primary_10_17826_cumj_1366249 crossref_primary_10_1016_j_earlhumdev_2023_105844 crossref_primary_10_1038_s41598_025_13696_8 crossref_primary_10_1016_j_oret_2022_03_005 crossref_primary_10_3390_pediatric16030050 crossref_primary_10_1038_s41372_023_01839_6 crossref_primary_10_3389_fped_2022_785292 crossref_primary_10_7759_cureus_85431 crossref_primary_10_1016_j_optom_2022_08_001 crossref_primary_10_1038_s41597_024_03362_5 crossref_primary_10_3390_biomedicines13010110 crossref_primary_10_4103_ijo_IJO_1538_22 crossref_primary_10_1038_s41598_024_58523_8 crossref_primary_10_4103_IJO_IJO_2177_24 crossref_primary_10_1038_s41372_025_02368_0 crossref_primary_10_1136_bjo_2025_327597 crossref_primary_10_1016_j_jpeds_2024_113913 crossref_primary_10_1016_j_survophthal_2022_11_007 crossref_primary_10_1080_14767058_2023_2228455 crossref_primary_10_7759_cureus_60005 crossref_primary_10_1016_j_ajpath_2023_07_006 crossref_primary_10_3389_fped_2024_1382858 crossref_primary_10_1001_jama_2022_10564 crossref_primary_10_1177_19345798251372547 crossref_primary_10_1136_bmjophth_2025_002303 crossref_primary_10_3389_fped_2024_1440437 crossref_primary_10_1016_j_exer_2024_110158 crossref_primary_10_3390_biomedicines10071603 crossref_primary_10_1001_jamaophthalmol_2024_5533 crossref_primary_10_1038_s41746_023_00943_3 crossref_primary_10_1016_j_ophtha_2021_10_021 crossref_primary_10_1016_j_ophtha_2021_10_020 crossref_primary_10_1111_aos_16788 crossref_primary_10_1016_j_jaapos_2023_08_009 crossref_primary_10_1159_000543659 crossref_primary_10_1167_iovs_64_7_11 crossref_primary_10_1055_a_1758_3020 crossref_primary_10_3389_fped_2021_796143 crossref_primary_10_1016_j_cegh_2024_101530 crossref_primary_10_1016_j_farma_2024_04_017 crossref_primary_10_1080_08820538_2022_2085518 crossref_primary_10_3389_fped_2023_1195904 crossref_primary_10_4103_IJO_IJO_2714_23 crossref_primary_10_1136_bmjophth_2025_002239 crossref_primary_10_1007_s10462_025_11153_6 crossref_primary_10_1109_JBHI_2022_3229743 crossref_primary_10_7759_cureus_81262 crossref_primary_10_1016_j_knosys_2023_110461 crossref_primary_10_1155_2022_6266528 crossref_primary_10_1186_s12886_025_03865_8 crossref_primary_10_1007_s42452_025_06731_w crossref_primary_10_1016_j_jaapos_2025_104280 crossref_primary_10_1001_jamaophthalmol_2023_1466 crossref_primary_10_1038_s41390_025_03935_z crossref_primary_10_1038_s41433_024_03260_5 crossref_primary_10_1016_j_ophtha_2024_09_011 crossref_primary_10_1016_j_xops_2025_100857 crossref_primary_10_7759_cureus_80266 crossref_primary_10_1016_j_ophtha_2025_01_004 crossref_primary_10_1038_s41597_024_03409_7 crossref_primary_10_1016_j_oret_2025_01_012 crossref_primary_10_1016_j_oftale_2024_05_005 crossref_primary_10_1016_j_mex_2025_103182 crossref_primary_10_1186_s12887_024_04611_7 crossref_primary_10_3389_fped_2023_1273413 crossref_primary_10_1038_s41433_024_03285_w crossref_primary_10_1016_j_ajo_2025_02_040 crossref_primary_10_1109_TMI_2023_3278269 crossref_primary_10_3389_fped_2023_1055813 crossref_primary_10_4103_IJO_IJO_408_24 crossref_primary_10_1038_s41598_024_52407_7 crossref_primary_10_4103_sjopt_sjopt_63_23 crossref_primary_10_7189_jogh_13_03028 crossref_primary_10_7759_cureus_63712 crossref_primary_10_1542_peds_2021_053255 crossref_primary_10_1055_a_2496_2310 crossref_primary_10_1111_jpc_16777 crossref_primary_10_1007_s10384_025_01279_z crossref_primary_10_1016_j_ophtha_2022_05_019 crossref_primary_10_1186_s40942_025_00635_y crossref_primary_10_1002_14651858_CD001072_pub2 crossref_primary_10_1186_s13052_024_01747_1 crossref_primary_10_1002_ppul_27216 crossref_primary_10_1167_iovs_66_11_17 crossref_primary_10_1016_j_survophthal_2025_06_007 crossref_primary_10_1038_s41572_024_00501_5 crossref_primary_10_1016_j_ophtha_2024_06_006 crossref_primary_10_1016_j_jaapos_2022_07_001 crossref_primary_10_3390_diagnostics12051251 crossref_primary_10_1146_annurev_vision_093022_021420 crossref_primary_10_4103_ijo_IJO_1712_22 crossref_primary_10_7189_jogh_15_04168 crossref_primary_10_1109_TCBB_2023_3234100 crossref_primary_10_1186_s40942_022_00402_3 crossref_primary_10_36660_abc_20240635i crossref_primary_10_3389_fmed_2022_850129 crossref_primary_10_1111_apa_70216 crossref_primary_10_1016_j_dsp_2025_105548 crossref_primary_10_3390_nu17101726 crossref_primary_10_1007_s00431_025_06169_7 crossref_primary_10_3390_children11101179 crossref_primary_10_1111_ceo_14441 crossref_primary_10_1007_s00431_025_06147_z crossref_primary_10_4103_IJO_IJO_1542_24 crossref_primary_10_1038_s41433_022_02374_y crossref_primary_10_1136_bjo_2023_323915 crossref_primary_10_3389_fped_2023_1191174 crossref_primary_10_3389_fped_2025_1491976 crossref_primary_10_3389_fphar_2022_835771 crossref_primary_10_1016_j_oret_2025_07_003 crossref_primary_10_1364_BOE_569243 crossref_primary_10_1016_j_yaoo_2025_03_005 crossref_primary_10_4103_IJO_IJO_415_23 crossref_primary_10_1186_s13052_025_02094_5 crossref_primary_10_1007_s42399_025_01819_1 crossref_primary_10_1038_s41433_024_03506_2 crossref_primary_10_1111_ceo_14575 crossref_primary_10_3390_children10030567 crossref_primary_10_1001_jamanetworkopen_2024_23933 crossref_primary_10_1007_s00417_024_06402_3 crossref_primary_10_4103_ojo_ojo_222_22 crossref_primary_10_3390_jcm12196374 crossref_primary_10_3390_life13051075 crossref_primary_10_17826_cumj_1460277 crossref_primary_10_1007_s00417_022_05663_0 crossref_primary_10_5409_wjcp_v11_i3_215 crossref_primary_10_1038_s41390_025_04276_7 crossref_primary_10_1002_ppul_71281 crossref_primary_10_1186_s40348_023_00163_5 crossref_primary_10_1007_s00417_025_06838_1 crossref_primary_10_1186_s12886_024_03759_1 crossref_primary_10_1038_s41598_022_08680_5 crossref_primary_10_1080_14767058_2025_2454374 crossref_primary_10_3390_children11101154 crossref_primary_10_1111_ceo_14598 crossref_primary_10_4103_sjopt_sjopt_20_22 crossref_primary_10_1167_iovs_66_6_61 crossref_primary_10_1038_s41598_022_15804_4 crossref_primary_10_1136_bcr_2023_259537 crossref_primary_10_1136_bjo_2023_323723 crossref_primary_10_1136_bmjopen_2023_083508 crossref_primary_10_3928_01913913_20220609_02 crossref_primary_10_1038_s41598_022_15217_3 crossref_primary_10_1038_s41372_024_02134_8 crossref_primary_10_1186_s12886_023_02886_5 crossref_primary_10_3346_jkms_2025_40_e258 crossref_primary_10_1177_11206721221132869 crossref_primary_10_2147_JMDH_S528155 crossref_primary_10_1016_j_oret_2023_04_013 crossref_primary_10_4102_jcmsa_v3i1_220 crossref_primary_10_1016_j_oret_2022_02_006 crossref_primary_10_3389_fped_2023_1203068 crossref_primary_10_3389_fped_2024_1450121 crossref_primary_10_4103_ojo_ojo_167_23 crossref_primary_10_1038_s41433_025_03735_z crossref_primary_10_3928_23258160_20231206_03 crossref_primary_10_1038_s41598_023_47212_7 crossref_primary_10_1111_aos_17461 crossref_primary_10_1080_2576117X_2023_2287633 crossref_primary_10_1186_s12887_024_04741_y crossref_primary_10_2147_IJGM_S401122 crossref_primary_10_1097_MD_0000000000042702 crossref_primary_10_1002_ppul_27384 crossref_primary_10_1016_j_ophtha_2022_02_008 crossref_primary_10_1038_s41433_025_03896_x crossref_primary_10_1007_s10792_025_03461_1 crossref_primary_10_3928_23258160_20231020_01 crossref_primary_10_1007_s00347_025_02220_y crossref_primary_10_1186_s12886_024_03836_5 crossref_primary_10_1016_j_oret_2023_09_001 crossref_primary_10_1186_s12886_022_02252_x crossref_primary_10_1016_j_oftal_2024_03_012 crossref_primary_10_1001_jamaophthalmol_2022_4326 crossref_primary_10_5409_wjcp_v12_i4_220 crossref_primary_10_3389_fped_2022_792724 crossref_primary_10_3390_pediatric16030069 crossref_primary_10_1016_j_phrs_2022_106416 crossref_primary_10_1007_s00431_024_05632_1 crossref_primary_10_1016_j_oret_2023_10_004 crossref_primary_10_1016_j_oret_2023_10_003 crossref_primary_10_3928_23258160_20230626_01 crossref_primary_10_1007_s40746_022_00249_8 crossref_primary_10_3389_fped_2022_870125 crossref_primary_10_1001_jamaophthalmol_2024_0045 crossref_primary_10_3390_nu15153290 crossref_primary_10_3390_jcm12175644 crossref_primary_10_1177_11206721231200666 crossref_primary_10_1007_s11010_022_04394_4 crossref_primary_10_1016_j_arbres_2023_01_003 crossref_primary_10_1136_bmjopen_2024_085560 crossref_primary_10_1097_APO_0000000000000638 crossref_primary_10_1186_s13063_023_07745_8 crossref_primary_10_18621_eurj_1610415 crossref_primary_10_1371_journal_pone_0322941 crossref_primary_10_4103_IJO_IJO_2544_23 crossref_primary_10_1097_IAE_0000000000004032 crossref_primary_10_1080_02713683_2025_2503202 crossref_primary_10_4274_forbes_galenos_2024_66933 crossref_primary_10_1097_IIO_0000000000000448 crossref_primary_10_3389_fphar_2022_759742 crossref_primary_10_1016_j_ophtha_2022_01_025 crossref_primary_10_1016_j_oret_2025_05_008 crossref_primary_10_1155_int_6688133 crossref_primary_10_1109_ACCESS_2024_3509441 crossref_primary_10_1007_s10384_024_01084_0 crossref_primary_10_1111_aos_15800 crossref_primary_10_2147_PHMT_S391591 crossref_primary_10_1891_NN_2022_0054 crossref_primary_10_1016_j_exer_2023_109773 crossref_primary_10_1088_2057_1976_ad91ba crossref_primary_10_3389_fped_2022_1077137 crossref_primary_10_3390_life15091463 crossref_primary_10_1177_19345798251353790 crossref_primary_10_3390_nu17132177 crossref_primary_10_1016_j_ajo_2025_07_023 crossref_primary_10_1186_s12887_024_04571_y crossref_primary_10_7759_cureus_88021 crossref_primary_10_1039_D5BM00555H crossref_primary_10_1001_jamaophthalmol_2022_2135 crossref_primary_10_1002_14651858_CD013294_pub2 crossref_primary_10_1016_j_lansea_2023_100210 crossref_primary_10_1038_s41433_023_02603_y crossref_primary_10_4103_joco_joco_38_23 crossref_primary_10_1016_j_clinthera_2024_08_011 crossref_primary_10_1136_bmjophth_2021_000911 crossref_primary_10_1038_s41598_025_10859_5 crossref_primary_10_1186_s13052_024_01781_z crossref_primary_10_3389_fped_2024_1381193 crossref_primary_10_1093_tropej_fmae049 crossref_primary_10_1111_apa_70041 crossref_primary_10_1007_s40123_023_00744_7 crossref_primary_10_1016_j_jaapos_2024_104101 crossref_primary_10_1038_s41390_023_02673_4 crossref_primary_10_1016_j_ajpath_2023_02_003 crossref_primary_10_3390_children12040509 crossref_primary_10_3928_01913913_20240508_05 crossref_primary_10_1186_s12886_023_02810_x crossref_primary_10_2147_OPTH_S383493 crossref_primary_10_1038_s41598_024_82445_0 crossref_primary_10_1111_dmcn_15468 crossref_primary_10_1136_bmjophth_2021_000923 crossref_primary_10_3389_fped_2023_1298173 crossref_primary_10_1097_IAE_0000000000004067 crossref_primary_10_1007_s13167_024_00350_y crossref_primary_10_4103_tjo_TJO_D_23_00028 crossref_primary_10_1097_ICU_0000000000000786 crossref_primary_10_3389_fped_2023_1238193 crossref_primary_10_1016_j_ophtha_2024_05_019 crossref_primary_10_1136_bmjophth_2023_001257 crossref_primary_10_1177_11206721221126286 crossref_primary_10_2147_OPTH_S383497 crossref_primary_10_1038_s41433_024_02953_1 crossref_primary_10_1177_11206721231178062 crossref_primary_10_1038_s41598_023_42150_w crossref_primary_10_3390_ijms232214199 crossref_primary_10_1016_j_arcmed_2024_102967 crossref_primary_10_1097_IAE_0000000000004232 crossref_primary_10_1097_IAE_0000000000004231 crossref_primary_10_1016_j_earlhumdev_2024_106053 crossref_primary_10_4103_tjo_TJO_D_24_00020 crossref_primary_10_1038_s41372_023_01657_w crossref_primary_10_4103_tjo_TJO_D_24_00021 crossref_primary_10_3390_children11121538 crossref_primary_10_1002_mco2_668 crossref_primary_10_1136_bcr_2024_261741 crossref_primary_10_12677_acrem_2025_132026 crossref_primary_10_1016_j_ophtha_2021_07_014 crossref_primary_10_3390_children12091215 crossref_primary_10_3390_jcm12031228 crossref_primary_10_1007_s00347_023_01876_8 crossref_primary_10_1542_peds_2023_064153 crossref_primary_10_1007_s11042_023_15430_w crossref_primary_10_1080_02713683_2022_2139847 crossref_primary_10_1007_s10792_022_02321_6 crossref_primary_10_1007_s15010_024_02435_2 crossref_primary_10_1007_s00417_024_06668_7 crossref_primary_10_7759_cureus_19267 crossref_primary_10_1001_jamaophthalmol_2022_0030 crossref_primary_10_4103_ijo_IJO_243_22 crossref_primary_10_4103_tjo_TJO_D_24_00157 crossref_primary_10_1007_s00431_025_06042_7 crossref_primary_10_1186_s13052_024_01629_6 crossref_primary_10_1272_jnms_JNMS_2025_92_307 crossref_primary_10_1007_s10792_024_03311_6 crossref_primary_10_1038_s41433_022_02366_y crossref_primary_10_1177_09732179251341073 crossref_primary_10_1002_jpr3_12036 crossref_primary_10_1016_j_oret_2024_04_025 crossref_primary_10_1097_IIO_0000000000000552 crossref_primary_10_1136_bmjophth_2022_001166 crossref_primary_10_1542_peds_2021_053924 crossref_primary_10_7759_cureus_76000 crossref_primary_10_1136_bmjophth_2022_001173 crossref_primary_10_7759_cureus_75029 crossref_primary_10_4103_sjopt_sjopt_12_22 crossref_primary_10_1007_s10792_022_02540_x crossref_primary_10_1016_j_matdes_2023_112240 crossref_primary_10_2196_60367 crossref_primary_10_1016_j_exer_2023_109518 crossref_primary_10_1016_j_preteyeres_2023_101208 crossref_primary_10_3390_jcm13041140 crossref_primary_10_4103_IJO_IJO_889_23 crossref_primary_10_1002_ppul_71127 crossref_primary_10_3390_ijms24032416 crossref_primary_10_1001_jamaophthalmol_2022_1344 crossref_primary_10_1016_j_jpeds_2025_114711 crossref_primary_10_1038_s41598_025_15856_2 |
| ContentType | Journal Article |
| Copyright | Published by Elsevier Inc. |
| Copyright_xml | – notice: Published by Elsevier Inc. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.ophtha.2021.05.031 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1549-4713 |
| ExternalDocumentID | 34247850 |
| Genre | Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NEI NIH HHS grantid: U01 EY028079 – fundername: NEI NIH HHS grantid: P30 EY005722 – fundername: NEI NIH HHS grantid: R01 EY025009 |
| GroupedDBID | --- --K .1- .55 .FO .GJ 0R~ 123 1B1 1CY 1P~ 1~5 29N 4.4 457 4G. 53G 5RE 5VS 7-5 71M AAEDT AAEDW AALRI AAQFI AAQQT AAQXK AAXUO ABCQX ABFRF ABJNI ABLJU ABMAC ABOCM ABWVN ACGFO ACGFS ACIUM ACNCT ACRPL ACVFH ADCNI ADMUD ADNMO AEFWE AENEX AEUPX AEVXI AFFNX AFJKZ AFPUW AFRHN AFTJW AGCQF AGQPQ AIGII AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BELOY C5W CGR CS3 CUY CVF DU5 EBS ECM EFJIC EFKBS EIF EJD F5P FDB FEDTE FGOYB GBLVA HVGLF HZ~ IHE J1W K-O KOM L7B M27 M41 MO0 N4W N9A NPM NQ- O9- OF- OPF OQ~ P2P R2- RIG ROL RPZ SDG SEL SES SSZ UHS UNMZH UV1 WH7 X7M XH2 XPP Z5R ZGI ZXP 7X8 |
| ID | FETCH-LOGICAL-c564t-344eb34df42ec3b962aca42542fb48f3e762f3b58881f66f0791e49d497c0b0b2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 345 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000710468700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1549-4713 |
| IngestDate | Sun Sep 28 09:58:54 EDT 2025 Mon Jul 21 06:07:03 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10 |
| Keywords | Neonatology Retina Retinopathy of prematurity Prematurity Pediatric ophthalmology |
| Language | English |
| License | Published by Elsevier Inc. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c564t-344eb34df42ec3b962aca42542fb48f3e762f3b58881f66f0791e49d497c0b0b2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | http://hdl.handle.net/10072/426807 |
| PMID | 34247850 |
| PQID | 2550632629 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2550632629 pubmed_primary_34247850 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-10-01 |
| PublicationDateYYYYMMDD | 2021-10-01 |
| PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Ophthalmology (Rochester, Minn.) |
| PublicationTitleAlternate | Ophthalmology |
| PublicationYear | 2021 |
| References | 34332760 - Ophthalmology. 2021 Oct;128(10):1381-1383 35256217 - Ophthalmology. 2022 Jun;129(6):e64-e65 34844764 - Ophthalmology. 2022 Mar;129(3):e36 34844763 - Ophthalmology. 2022 Mar;129(3):e36-e37 |
| References_xml | – reference: 34332760 - Ophthalmology. 2021 Oct;128(10):1381-1383 – reference: 34844764 - Ophthalmology. 2022 Mar;129(3):e36 – reference: 34844763 - Ophthalmology. 2022 Mar;129(3):e36-e37 – reference: 35256217 - Ophthalmology. 2022 Jun;129(6):e64-e65 |
| SSID | ssj0006634 |
| Score | 2.7349315 |
| SecondaryResourceType | review_article |
| Snippet | The International Classification of Retinopathy of Prematurity is a consensus statement that creates a standard nomenclature for classification of retinopathy... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | e51 |
| SubjectTerms | Diagnostic Imaging Disease Progression Gestational Age Humans Infant, Newborn Retina - diagnostic imaging Retinopathy of Prematurity - classification Retinopathy of Prematurity - diagnosis |
| Title | International Classification of Retinopathy of Prematurity, Third Edition |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/34247850 https://www.proquest.com/docview/2550632629 |
| Volume | 128 |
| WOSCitedRecordID | wos000710468700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8NAFH6oFfHivtSNCB4dTGZeMpmTiLTooaVIhd5CZ6NektpWwX_vzCSlCB4EL4EJBMKbN2-f7wO4ia1KpEQkSo8lQWuRiJwawlGKVKOyGmuyCd7v56ORGDQFt3kzVrm0icFQ60r5GvmdC32dN6UZFffTd-JZo3x3taHQWIcWc6GM12o-WqGFO28ausouByLOCLPl1bkw31VNJ4uJRx6iScDubGjmfg0yg7Pp7v73N_dgpwkzo4daL_ZhzZQHsNVrGumH8PyjEhgFakw_NBReRJWNXvxV6MrzFX_55WDmsV0D091tNJy8zXTU0WHa6wheu53h4xNpWBWISjNcEIboEmjUFqlRTIqMjtXYnVykVmJumXHm0TKZutQ4sVlmYy4Sg0Kj4CqWsaTHsFFWpTmFyPAUpTY0yXSMic2FtDxXPFaKMpNq3YbrpZAKp7W-FTEuTfUxL1ZiasNJLeliWsNrFAwp8jyNz_7w9Tls-w2sp-suoGXdmTWXsKk-F2_z2VVQB_fsD3rfmUDASg |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=International+Classification+of+Retinopathy+of+Prematurity%2C+Third+Edition&rft.jtitle=Ophthalmology+%28Rochester%2C+Minn.%29&rft.au=Chiang%2C+Michael+F&rft.au=Quinn%2C+Graham+E&rft.au=Fielder%2C+Alistair+R&rft.au=Ostmo%2C+Susan+R&rft.date=2021-10-01&rft.issn=1549-4713&rft.eissn=1549-4713&rft.volume=128&rft.issue=10&rft.spage=e51&rft_id=info:doi/10.1016%2Fj.ophtha.2021.05.031&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-4713&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-4713&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-4713&client=summon |